SPONSOR

Emory University

Total Trials

Recruiting

Phases

Phase 2, Phase 4

Emory University is a clinical research sponsor with 27 registered studies on ClinicalTrials.gov, of which 27 are actively recruiting participants. Research covers conditions including Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma.

The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Emory University

How many clinical trials has Emory University sponsored?

ClinicalMetric currently tracks 27 clinical trials sponsored by Emory University, of which 27 are actively recruiting participants. These trials cover conditions including Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma of Unknown Primary. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Emory University research focus on?

Emory University clinical trials span Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Emory University clinical trial?

To participate in a Emory University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Emory University trials with current recruitment status updated daily.

Emory University

Frequently Asked Questions — Emory University

Clinical Trials by Emory University

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Effect of Cognitive Empathy Training on Dementia Caregivers

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment

AB Gait Estim Neurophysiology

Treatment of Hemophilia A Patients With FVIII Inhibitors

Sympathetic Overactivity in Post-traumatic Stress Disorder

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

A Smoke-Free Home Intervention in Tribal Communities

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Childhood Cancer Predisposition Study (CCPS)

GAMES Intervention in MCI (Mild Cognitive Impairment)

Trial of Community-based Patient Navigation

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

Communication Issues in Patient and Provider Discussions of Immunotherapy

FEED-Cystic Fibrosis (FEED-CF)

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Spatial-Motor Stroke-Rehab Study

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Strategies for Implementing GlobalConsent to Prevent Sexual Violence in University Men

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Pectoralis Minor Release Versus Non-release in RSA

Visual Influences on Vestibular Adaptation